Presumably, cancer cells exploit alterations of ATM/CHK2/p53to avoid cell cycle exit at the G1 phase and rely on ATR/CHK1/WEE1 activity to handle a high level of RS during continuous cell division. This evidence concerns the gene CHEK2 and cancer.